Uneek Mehra

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Signature
/s/ Scott Bizily as Attorney-in-Fact for Uneek Mehra
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Uneek Mehra:

Stock Role Class Num Shares Value Price $ Report Date Ownership
4D Molecular Therapeutics, Inc. Chief Financial & Business Officer Stock Option (Right to Buy) 130K Mar 6, 2025 Direct
Myovant Sciences Ltd. Principal Financial Officer Common Shares 0 $27.00 Mar 10, 2023 Direct
Myovant Sciences Ltd. Principal Financial Officer Performance Stock Unit 0 Mar 10, 2023 Direct
Myovant Sciences Ltd. Principal Financial Officer Stock Options (Right to Buy) 0 Mar 10, 2023 Direct

Insider Reports Filed by Uneek Mehra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FDMT 4D Molecular Therapeutics, Inc. Mar 6, 2025 1 $0 4 Mar 10, 2025 Chief Financial & Business Officer
FDMT 4D Molecular Therapeutics, Inc. Dec 11, 2023 1 $0 4 Dec 13, 2023 CHIEF FINANCIAL & BUSINESS OFFICER
FDMT 4D Molecular Therapeutics, Inc. Oct 1, 2023 1 $0 4 Oct 3, 2023 CHIEF FINANCIAL & BUSINESS OFFICER
FDMT 4D Molecular Therapeutics, Inc. Sep 22, 2023 0 $0 3 Sep 26, 2023 CHIEF FINANCIAL & BUSINESS OFFICER
MYOV Myovant Sciences Ltd. Mar 10, 2023 4 $0 4 Mar 10, 2023 Principal Financial Officer
MYOV Myovant Sciences Ltd. Dec 16, 2022 1 -$59.9K 4 Dec 20, 2022 Principal Financial Officer
MYOV Myovant Sciences Ltd. Sep 16, 2022 1 -$174K 4 Sep 20, 2022 Principal Financial Officer
MYOV Myovant Sciences Ltd. Apr 15, 2022 1 $0 4 Apr 19, 2022 Principal Financial Officer
MYOV Myovant Sciences Ltd. Sep 15, 2021 2 $0 4 Sep 17, 2021 Principal Financial Officer
MYOV Myovant Sciences Ltd. Sep 7, 2021 0 $0 3 Sep 9, 2021 Principal Financial Officer